Showing results (161-170 of 503) with videos related to
Sort By:
Pageof 51
Journal of Pharmaceutical Sciences|March 1, 1976
Anticonvulsant activity and selective inhibition of nicotinamide adenine dinucleotide-dependent oxidations by 10-(2-arylimino-3-acetylamino-4-thiazolidonyl) phenothiazinesS P Singh, B Ali, T K Auyong, et al.Journal of Pharmaceutical Sciences|March 1, 1976
CNS depressant activity of pyrimidylthiazolidones and their selective inhibition of NAD-dependent pyruvate oxidationM Chaudhary, S S Parmar, S K Chaudhary, et al.Clinical and Experimental Pharmacology & Physiology|January 1, 1985
Serotonin in toxaemia of pregnancyV R Gujrati, K Shanker, S S Parmar, et al.Journal of Pharmaceutical Sciences|June 1, 1975
Synthesis of 2-(N-arylcarboxamide)-3-substituted ethoxyindoles and their monoamine oxidase inhibitory and anticonvulsant activitiesA K Gupta, C Dwivedi, T K Gupta, et al.The Journal of Biological Chemistry|April 15, 2000
Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neuronsS L Chan, M Mayne, C P Holden, et al.Journal of Neurochemistry|August 3, 2001
HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicityN J Haughey, A Nath, M P Mattson, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|April 1, 1993
Generation of T-cells reactive to the poorly immunogenic B16-BL6 melanoma with efficacy in the treatment of spontaneous metastasesJ D Geiger, P D Wagner, M J Cameron, et al.Annals of Neurology|March 1, 1995
Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicityD S Magnuson, B E Knudsen, J D Geiger, et al.Pacing and Clinical Electrophysiology : PACE|September 1, 1981
Pacemaker malfunction following transthoracic countershockG Das, J EatonPageof 51